Headlines

Essilor International Gets New CEO

CHARENTON-LE-PONT, FRANCE – The board of directors of EssilorLuxottica has named Paul du Saillant as a director of the company in place of Laurent Vacherot, former CEO of Essilor International, who retired.

Effective immediately, du Saillant will take over Vacherot’s responsibilities, including the role of CEO for Essilor International and the coexecutive delegate powers previously granted to Vacherot on May 13, 2019, by Leonardo Del Vecchio, executive chairman, and Hubert Sagnières, executive vice chairman. He will work directly with Francesco Milleri, deputy chairman and CEO of Luxottica Group, “to develop and implement the EssilorLuxottica strategy and integration process,” according to a press release.

Eyecare Shenanigans

Eyecare Shenanigans: 2023’s Top Optometry Articles in Invision Magazine

INVISION Podcast

Bringing Independent ECPs Into the 21st Century With the Technology Solutions a Modern Eyecare Business Needs

INVISION Podcast

The Making of Bespoke Eyewear, An Acetate Kitchen and Collecting Famous People’s Heads

In light of the current COVID-19 outbreak, the board also decided today to postpone the Annual Shareholders’ Meeting from May 15 to June 25 and to hold it behind closed doors.

Additionally, the board decided to re-evaluate its previous decision on dividend distribution announced on March 6, 2020, at a later date. “At such later date, the Board of Directors may decide whether to confirm, reduce or cancel dividends based on the evolution of the situation,” according to the release.

Essilor and Luxottica completed a merger in October 2018 to form EssilorLuxottica. The organization was then plagued by infighting among its leadership.

In May 2019, a new settlement agreement addressed governance issues and set the basis for a “renewed start of profound collaboration” between Essilor and Luxottica.

Because of the COVID-19 crisis, “EssilorLuxottica and the two operating companies are implementing a contingency plan including cost and cash control measures, putting on hold non-crucial investment initiatives and rightsizing global capacity to meet current demand levels,” according to a March 27 press release.

The company stated that in light of the pandemic, its outlook for 2020 published on March 6 “is no longer valid.”

“During the second quarter, the Company expects revenue to further decelerate with a material impact on profitability,” the company stated. “At present, the Company has insufficient visibility to provide an assessment of the full scope of COVID-19 impact, as the situation remains volatile.”

INVISION Staff

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

Recent Posts

How Small Eyecare Businesses Can Afford Medical Benefits for Employees

It's about finding the right fit between valuable employee benefits and what's financially feasible for…

4 hours ago

Medical Advice Gone Wrong

Apparently, when providing treatment plans you must be very, very explicit…

4 hours ago

The Bottom Line: How to Stand Out When Hiring

Recruiting associate optometrists is vital to practice growth but with a shortage of ODs in…

4 hours ago

More Contact Lens Adoption Could Be as Easy as Talking About It and More of What You Need to Know for May

Plus the economic impact of better vision and enhanced online staff training resources.

5 hours ago

An Ultrasonic Cleaner for at Home Use and More Business Boosters for May

Plus labels, stickers and creepy little bling you can’t help but love.

5 hours ago

Your Letters to the Editor For May

"INVISION helped inspire me to become an independent. You have wonderful content. It is the…

6 hours ago

This website uses cookies.